Items per page
Sort by

Send to:

Choose Destination

Results: 10

Cited In for PubMed (Select 17320118)


Cannabinoids in experimental stroke: a systematic review and meta-analysis.

England TJ, Hind WH, Rasid NA, O'Sullivan SE.

J Cereb Blood Flow Metab. 2015 Mar;35(3):348-358. doi: 10.1038/jcbfm.2014.218. Epub 2014 Dec 10. Review.


Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Miljković D, Spasojević I.

Antioxid Redox Signal. 2013 Dec 20;19(18):2286-334. doi: 10.1089/ars.2012.5068. Epub 2013 Apr 22. Review.


Is the cardiovascular system a therapeutic target for cannabidiol?

Stanley CP, Hind WH, O'Sullivan SE.

Br J Clin Pharmacol. 2013 Feb;75(2):313-22. doi: 10.1111/j.1365-2125.2012.04351.x. Review.


Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?

Fernández-Ruiz J, Sagredo O, Pazos MR, García C, Pertwee R, Mechoulam R, Martínez-Orgado J.

Br J Clin Pharmacol. 2013 Feb;75(2):323-33. doi: 10.1111/j.1365-2125.2012.04341.x. Review.


Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus.

Rock EM, Bolognini D, Limebeer CL, Cascio MG, Anavi-Goffer S, Fletcher PJ, Mechoulam R, Pertwee RG, Parker LA.

Br J Pharmacol. 2012 Apr;165(8):2620-34. doi: 10.1111/j.1476-5381.2011.01621.x.


Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients.

Bergamaschi MM, Queiroz RH, Chagas MH, de Oliveira DC, De Martinis BS, Kapczinski F, Quevedo J, Roesler R, Schröder N, Nardi AE, Martín-Santos R, Hallak JE, Zuardi AW, Crippa JA.

Neuropsychopharmacology. 2011 May;36(6):1219-26. doi: 10.1038/npp.2011.6. Epub 2011 Feb 9.


Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion.

Walsh SK, Hepburn CY, Kane KA, Wainwright CL.

Br J Pharmacol. 2010 Jul;160(5):1234-42. doi: 10.1111/j.1476-5381.2010.00755.x.


Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors.

Zanelati TV, Biojone C, Moreira FA, Guimarães FS, Joca SR.

Br J Pharmacol. 2010 Jan;159(1):122-8. doi: 10.1111/j.1476-5381.2009.00521.x. Epub 2009 Dec 4.


Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice.

Capasso R, Borrelli F, Aviello G, Romano B, Scalisi C, Capasso F, Izzo AA.

Br J Pharmacol. 2008 Jul;154(5):1001-8. doi: 10.1038/bjp.2008.177. Epub 2008 May 12.


Cannabinoid control of neuroinflammation related to multiple sclerosis.

Baker D, Jackson SJ, Pryce G.

Br J Pharmacol. 2007 Nov;152(5):649-54. Epub 2007 Sep 24. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk